Kingfisher Capital’s iShares Biotechnology ETF IBB Stock Holding History

Kingfisher Capital’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$262K	Buy	1,800 +2	+0.1%	+$289	0.06%	160
2024 Q2	$247K	Hold	1,798	–	–	0.06%	155
2024 Q1	$247K	Buy	1,798 +2	+0.1%	+$273	0.06%	148
2023 Q4	$244K	Buy	1,796 +4	+0.2%	+$488	0.06%	150
2023 Q3	$219K	Hold	1,792	–	–	0.06%	149
2023 Q2	$228K	Hold	1,792	–	–	0.06%	155
2023 Q1	$231K	Buy	1,792 +1	+0.1%	+$131	0.06%	155
2022 Q4	$235K	Sell	1,791 -278	-13%	-$35.9K	0.06%	153
2022 Q3	$242K	Buy	+2,069	New	+$257K	0.07%	158
2017 Q1	–	Sell	-6,759	Closed	-$598K	–	117
2016 Q4	$598K	Sell	6,759 -4,032	-37%	-$367K	0.45%	83
2016 Q3	$1.04M	Buy	+10,791	New	+$1.03M	0.73%	64

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Kingfisher Capital's IBB Position: Q3 2024 in Review

Kingfisher Capital increased its iShares Biotechnology ETF (IBB) stake by 0.11% in Q3 2024, buying an estimated $289 and bringing the position to 1,800 shares worth $262K. The position accounts for 0.06% of the portfolio, ranked #160.

Kingfisher Capital first reported a position in IBB in Q3 2016 and has held it in 11 quarters since. The position peaked at $1.04M in Q3 2016. 893 funds tracked by Wall St. Rank hold IBB as of Q3 2024.

Kingfisher Capital held 1,800 shares of iShares Biotechnology ETF worth $262K as of Q3 2024.
Kingfisher Capital bought 2 iShares Biotechnology ETF shares in Q3 2024, an estimated $289.
iShares Biotechnology ETF made up 0.06% of Kingfisher Capital's portfolio in Q3 2024, its #160 holding.
Kingfisher Capital first reported a position in iShares Biotechnology ETF in Q3 2016 and has held it in 11 quarters since.
Kingfisher Capital's iShares Biotechnology ETF position peaked at $1.04M in Q3 2016.
893 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2024.

Based on Kingfisher Capital's 13F filing for Q3 2024, filed 14 Nov 2024.